Evaluation of cfDNA mutation spectrum in metastatic breast cancer

被引：0
|
作者：
Shibayama, Tomoko [1 ]
Kobayashi, Takayuki [1 ]
Ohno, Shinji [1 ]
Ito, Yoshinori [1 ]
Ueno, Takayuki [1 ]
Ono, Makiko [2 ]
Takahashi, Shunji [2 ]
Siew-Kee, Low [3 ]
机构：
[1] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan
[2] Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan
[3] JFCR, Canc Precis Med Ctr, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2016
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [1] cfDNA mutation frequency in early stage breast cancer
    Kota, Karthik Joshua
    Gyanchandani, Rekha
    Rosenzweig, Margaret Quinn
    Brufsky, Adam
    Huggins-Puhalla, Shannon Leigh
    Miller, Lori
    Oesterreich, Steffi
    Lee, Adrian V.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers
    Verret, Benjamin
    Sourisseau, Tony
    Stefanovska, Bojana
    Mosele, Fernanda
    Tran-Dien, Alicia
    Andre, Fabrice
    CANCER RESEARCH, 2020, 80 (15) : 3062 - 3069
  • [3] Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer
    Bar, Yael
    Keenan, Jennifer C.
    Niemierko, Andrzej
    Medford, Arielle J.
    Isakoff, Steven J.
    Ellisen, Leif W.
    Bardia, Aditya
    Vidula, Neelima
    NPJ BREAST CANCER, 2024, 10 (01)
  • [4] Somatic BRCA Mutation in Metastatic Breast Cancer
    Minick, Tristan B.
    Norman, Robert A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [5] Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
    Barbirou, Mouadh
    Miller, Amanda A.
    Gafni, Erik
    Mezlini, Amel
    Zidi, Asma
    Boley, Nathan
    Tonellato, Peter J.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
    Mouadh Barbirou
    Amanda A. Miller
    Erik Gafni
    Amel Mezlini
    Asma Zidi
    Nathan Boley
    Peter J. Tonellato
    Scientific Reports, 12
  • [7] Biomarkers for Palbociclib in Fulvestrant-Resistant Metastatic Breast Cancer Using cfDNA Cancer Panel Sequencing
    Takeshita, Takashi
    Iwamoto, Takayuki
    Niikura, Naoki
    Watanabe, Kenichi
    Kikawa, Yuichiro
    Kobayashi, Kokoro
    Okamura, Takuho
    Tada, Hiroshi
    Ozaki, Shinji
    Toh, Uhi
    Yamamoto, Yutaka
    Tsuneizumi, Michiko
    Ishiguro, Hiroshi
    Masuda, Norikazu
    Saji, Shigehira
    CANCER SCIENCE, 2025, 116 : 1890 - 1890
  • [8] Mutation in Estrogen Receptor in Metastatic Breast Cancer in Japan
    Takeshima, Kaoru
    Hayashida, Tetsu
    Maeda, Hinako
    Nakashoji, Ayako
    Yokoe, Takamichi
    Seki, Tomoko
    Takahashi, Maiko
    Kitagawa, Yuko
    CANCER SCIENCE, 2018, 109 : 972 - 972
  • [9] Changes in the Genomic Spectrum of Actionable Alterations in HER2 Negative Metastatic Breast Cancer in Serial Cell Free DNA (cfDNA) Analysis
    Bar, Yael
    Keenan, Jennifer C.
    Ryan, Lianne
    Juric, Dejan
    Shin, Jennifer
    Wander, Seth A.
    Spring, Laura M.
    Moy, Beverly
    Ellisen, Leif
    Isakoff, Steven J.
    Bardia, Aditya
    Vidula, Neelima
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Mutational spectrum and tumor response in metastatic breast cancer
    Soucier-Ernst, D.
    Colameco, C.
    Troxel, A. B.
    Clark, C.
    Shih, N.
    Maxwell, K. N.
    Morrissette, J.
    Lieberman, D.
    Feldman, M.
    Goodman, N.
    Bradbury, A.
    Clark, A.
    Domchek, S.
    Fox, K.
    Glick, J.
    Matro, J.
    Nathanson, K.
    Chodosh, L.
    DeMichele, A.
    CANCER RESEARCH, 2016, 76
12345